Hypervision Surgical graduated from the 2021/2022 Health stream of the Creative Destruction Lab (CDL) programme at the University of Oxford’s Saïd Business School as 1 of only 8 companies and was selected as the single company to represent CDL-Oxford in the CDL Super Session on 23 June 2022.
Read moreHypervision Surgical continues to attract new talent to develop its hyperspectral imaging technology for surgery and welcomes its second intern.
Read moreThe Royal Academy of Engineering Enterprise Hub continues to provide dedicated support to Hypervision Surgical by furthering its business expansion work in the United States.
Read moreHypervision Surgical continues to attract new talent and welcomes its first intern. Xiaoyu Zhao is an MEng student in Biomedical Engineering at Imperial College London and brings over three years of R&D experience in biomedical Raman spectroscopy imaging and analysis.
Read moreOur CEO and co-founder Michael Ebner featured in this month’s Spotlight Series of the Royal Academy of Engineering (RAEng) Enterprise Hub about Hypervision Surgical.
Read moreHypervision Surgical continues to grow its team to develop its next-generation imaging technology. Dr Mirek Janatka has a wealth of experience in developing endoscopic devices and visual enhancement systems.
Read more
